[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"kb-mixing-peptides-zh":3},{"_path":4,"_dir":5,"_draft":6,"_partial":6,"_locale":7,"title":8,"description":9,"date":10,"dateLabel":11,"updated":12,"read":13,"author":14,"image":15,"faq":16,"body":35,"_type":667,"_id":668,"_source":669,"_file":670,"_stem":671,"_extension":672},"\u002Fmixing-peptides\u002Fzh","mixing-peptides",false,"","多种肽共用一支注射器：pH 值与析出","几种肽溶液一进同一支针管，为什么会突然发浑：pH 值、等电点、盐析效应，以及怎样认出一份已经析出的配液。","2026-08-07","2026年9月","2026-09-04","9 分钟","myPeptides Team","\u002Fassets\u002Fmixing-peptides_hero.png",[17,20,23,26,29,32],{"q":18,"a":19},"混合后的注射器变浑浊意味着什么","浑浊、白色丝状物或者絮状物，说明肽已经脱离溶液，也就是析出。这是配液本身的物理变化，不是外观上的瑕疵。",{"q":21,"a":22},"肽溶液为什么一混合就析出","肽能待在溶液里，是因为分子带同种净电荷、彼此互斥。几种没有缓冲能力的溶液混到一起，pH 可能被推向某一种肽的等电点——净电荷在那里为零；也可能把盐浓度抬高到自由水不够用的程度。",{"q":24,"a":25},"肽的等电点是什么","等电点（缩写 pI）是肽的正负电荷恰好抵消、净电荷为零的那个 pH 值。溶解度在那里最低，所以溶液的 pH 越靠近 pI，肽掉出来的可能性越大。",{"q":27,"a":28},"肽溶液之间有配伍表可查吗","医院药学对已获批的注射液备有配伍表，数据来自实验室对浑浊、不溶性微粒、pH 位移和效价损失的逐项考察。科研级肽没有可比的数据，因此一种组合会怎么表现，推不出来。",{"q":30,"a":31},"析出物能重新溶开或者滤掉吗","加温或者轻轻滚动，有时能让析出物在外观上消失，但外观说明不了分子是否完整、是否已经形成聚集体。过滤会把颗粒连同其中未知比例的有效成分一并拿走。两条路都不能让配液回到一个已知的状态。",{"q":33,"a":34},"混合后的注射器很清澈，是不是就说明配伍没问题","不是。肉眼可见的析出只是最直白的那种失败；缓慢降解肽、或者把它推成可溶性聚集体的 pH 位移，留下的液体看上去完全澄清。没有浑浊，不等于有配伍性。",{"type":36,"children":37,"toc":643},"root",[38,46,52,57,70,76,81,90,95,103,108,113,125,137,142,166,183,188,200,212,218,230,242,254,260,265,270,275,300,305,315,320,325,374,379,485,490,496,517,522,527,531,535,539,543,547,551,555,559,563,568,572,577,628,633,638],{"type":39,"tag":40,"props":41,"children":43},"element","h1",{"id":42},"多种肽共用一支注射器",[44],{"type":45,"value":42},"text",{"type":39,"tag":47,"props":48,"children":49},"p",{},[50],{"type":45,"value":51},"本页内容仅供一般信息参考，既不是医疗建议，也不是使用建议。它讲的是两种肽溶液在同一支针管里相遇时，化学上会发生什么。文中提到的不少物质并未获批为药品，或者属于处方药。",{"type":39,"tag":47,"props":53,"children":54},{},[55],{"type":45,"value":56},"同时摆弄过好几支肽溶液的人，多半撞见过这一幕：第一种抽好，第二种，第三种，全都清得像水；第四种一进去，几秒钟内针管里就挂出白色的丝。",{"type":39,"tag":47,"props":58,"children":59},{},[60,62,68],{"type":45,"value":61},"这就是",{"type":39,"tag":63,"props":64,"children":65},"strong",{},[66],{"type":45,"value":67},"析出",{"type":45,"value":69},"（英文里叫 peptide crash）：有效成分从溶液里掉了出来。它不是外观上的小瑕疵，而是这份配液的终点。",{"type":39,"tag":71,"props":72,"children":74},"h2",{"id":73},"析出是什么样子",[75],{"type":45,"value":73},{"type":39,"tag":47,"props":77,"children":78},{},[79],{"type":45,"value":80},"下面两张照片就来自这样一个案例。三种肽溶液依次抽入，针管一直是清的，其中一种是随货配 0.9% 氯化钠稀释液的制剂；第四种加进去的是一种脂化的 GLP-1 类肽，混合液当场就变了：",{"type":39,"tag":47,"props":82,"children":83},{},[84],{"type":39,"tag":85,"props":86,"children":89},"img",{"alt":87,"src":88},"胰岛素注射器针管内在混合多种肽后出现明显的白色丝状物与条纹","\u002Fassets\u002Fpeptide_crash_syringe.jpg",[],{"type":39,"tag":47,"props":91,"children":92},{},[93],{"type":45,"value":94},"凑近看，那不是气泡，而是固体絮状物，正朝推杆一端聚集：",{"type":39,"tag":47,"props":96,"children":97},{},[98],{"type":39,"tag":85,"props":99,"children":102},{"alt":100,"src":101},"同一支注射器的特写：白色絮状沉淀悬浮在液体中","\u002Fassets\u002Fpeptide_crash_closeup.jpg",[],{"type":39,"tag":47,"props":104,"children":105},{},[106],{"type":45,"value":107},"诱因八成不在最后加进去的那一种，而在针管里原本就有的东西。",{"type":39,"tag":71,"props":109,"children":111},{"id":110},"析出时到底发生了什么",[112],{"type":45,"value":110},{"type":39,"tag":47,"props":114,"children":115},{},[116,118,123],{"type":45,"value":117},"肽能待在溶液里，是因为它的分子带",{"type":39,"tag":63,"props":119,"children":120},{},[121],{"type":45,"value":122},"同种电荷",{"type":45,"value":124},"，彼此互相排斥。这层电荷一旦被抵消，分子就贴到一起，长得太大而留不住，于是掉出来。",{"type":39,"tag":47,"props":126,"children":127},{},[128,130,135],{"type":45,"value":129},"正负电荷恰好抵消的那个 pH 值叫",{"type":39,"tag":63,"props":131,"children":132},{},[133],{"type":45,"value":134},"等电点",{"type":45,"value":136},"（pI）。在那里净电荷为零，排斥力消失——那也正是任何一种肽溶解度最低的地方。一句话概括：溶液的 pH 越靠近 pI，越容易析出。",{"type":39,"tag":71,"props":138,"children":140},{"id":139},"混合液滑向等电点的两条路",[141],{"type":45,"value":139},{"type":39,"tag":47,"props":143,"children":144},{},[145,157,159,164],{"type":39,"tag":63,"props":146,"children":147},{},[148,150,155],{"type":45,"value":149},"pH 被推偏。",{"type":39,"tag":63,"props":151,"children":152},{},[153],{"type":45,"value":154},"科研级肽几乎无一例外以不含缓冲液的冻干粉形式供货。这正是它与成品药之间那道关键差别：获批制剂里有一套缓冲体系把 pH 钉住。自己配出来的溶液",{"type":45,"value":156},"基本上没有缓冲能力",{"type":45,"value":158},"，加进去的任何东西都会立刻、毫无阻力地把 pH 推走。另外，合成肽默认以 ",{"type":39,"tag":63,"props":160,"children":161},{},[162],{"type":45,"value":163},"TFA 盐",{"type":45,"value":165},"（纯化环节残留的三氟乙酸）形式交付，少数是醋酸盐。这两种反离子都呈酸性，于是几支这样的溶液抽进同一支针管，混合液就往酸性一侧漂——GLP-1 类肽的等电点恰好落在那一侧。",{"type":39,"tag":47,"props":167,"children":168},{},[169,181],{"type":39,"tag":63,"props":170,"children":171},{},[172,174,179],{"type":45,"value":173},"盐浓度升高。",{"type":39,"tag":63,"props":175,"children":176},{},[177],{"type":45,"value":178},"第二个机制是",{"type":45,"value":180},"盐析",{"type":45,"value":182},"。盐离子把水分子拽在自己身边，这部分水便不再能拿去给肽做水化层。超过一定浓度，剩下的水不够用，肽就从溶液里出来——与 pH 无关，而在脂化肽身上有充分记载。",{"type":39,"tag":71,"props":184,"children":186},{"id":185},"为什么脂化肽是最薄弱的一环",[187],{"type":45,"value":185},{"type":39,"tag":47,"props":189,"children":190},{},[191,193,198],{"type":45,"value":192},"瑞他鲁肽（Retatrutide）是一种在任何地区都尚未获批为药品的在研化合物，属于",{"type":39,"tag":63,"props":194,"children":195},{},[196],{"type":45,"value":197},"脂化",{"type":45,"value":199},"肽：一条脂肪酸链让它与白蛋白结合，半衰期因此拉长。同一条链也让分子之间很容易互相缔合，它的等电点落在弱酸区，大约 4.5–5.5；几支酸性肽溶液混到一起之后，pH 恰好漂到这一带。这一化合物没有公开的配伍数据；就脂化肽这一类而言，有据可查的是离子强度升高会压低溶解度——这和已有的描述对得上：针管里有氯化钠时出现过析出，没有氯化钠时则没有。同为脂化的其他 GLP-1 类活性成分很少见到这样的描述，它们属于处方药——这更像是这个分子自己的脾气，而不是整个类别的通性。",{"type":39,"tag":47,"props":201,"children":202},{},[203,205,210],{"type":45,"value":204},"于是案例又回到眼前：",{"type":39,"tag":63,"props":206,"children":207},{},[208],{"type":45,"value":209},"盐最可能来自稀释液",{"type":45,"value":211},"。随货配一支 0.9% 氯化钠安瓿的制剂，处方里往往还带着缓冲盐和甘露醇，凡是它碰到的液体，离子强度都被抬高。这一类制剂通常都属于处方药；而对已获批的药品，厂家的产品说明书才是准绳。离子强度升高，加上 pH 已经滑向等电点，两件事凑到一起，正好把最不结实的那个分子挤出溶液。当场析出的那一种大概率没有问题，它只是在另外几种造出来的环境里，成了最脆弱的分子。",{"type":39,"tag":71,"props":213,"children":215},{"id":214},"为什么共用一支注射器本身就是个难题",[216],{"type":45,"value":217},"为什么“共用一支注射器”本身就是个难题",{"type":39,"tag":47,"props":219,"children":220},{},[221,223,228],{"type":45,"value":222},"医院药学为“两种注射液能不能共用一支注射器”维护着成套的",{"type":39,"tag":63,"props":224,"children":225},{},[226],{"type":45,"value":227},"配伍表",{"type":45,"value":229},"。它们之所以存在，是因为答案推不出来：每一种组合都要在实验室里考察浑浊、不溶性微粒、pH 位移和效价损失。",{"type":39,"tag":47,"props":231,"children":232},{},[233,235,240],{"type":45,"value":234},"科研级肽",{"type":39,"tag":63,"props":236,"children":237},{},[238],{"type":45,"value":239},"没有",{"type":45,"value":241},"这样的表。哪一种化合物对另一种会怎样、按什么顺序、在什么浓度、用什么稀释液，都没有公开数据。针管里的一次混合，是样本量为一的实验。",{"type":39,"tag":47,"props":243,"children":244},{},[245,247,252],{"type":45,"value":246},"而且",{"type":39,"tag":63,"props":248,"children":249},{},[250],{"type":45,"value":251},"看得见的只是其中一部分",{"type":45,"value":253},"。带絮状物的析出一眼就能认出来；慢慢降解肽、或者把它推成可溶性聚集体的 pH 位移，看不出来。一支清澈的混合注射器不能证明一切正常，它只是没有出现反面的证据。",{"type":39,"tag":71,"props":255,"children":257},{"id":256},"第二类错误浓度对不上了",[258],{"type":45,"value":259},"第二类错误：浓度对不上了",{"type":39,"tag":47,"props":261,"children":262},{},[263],{"type":45,"value":264},"共用一支针管的代价，化学只占一半，另一半是账。胰岛素注射器上的一格刻度代表的是体积；只有在浓度已知的前提下，体积才代表某个量的有效成分。两种浓度不同的溶液进了同一支针管，得到的混合液成分已经无法从刻度上读出来，而部分析出又拿走了一个未知的份额。这类浓度混淆是独立于 pH 的另一类错误，也正是“一瓶一算”这条做法的由来。",{"type":39,"tag":71,"props":266,"children":268},{"id":267},"这样一份配液还值多少",[269],{"type":45,"value":267},{"type":39,"tag":47,"props":271,"children":272},{},[273],{"type":45,"value":274},"一文不值。注射器和针头进锐器盒，而不是退回任何一支西林瓶。背后的理由很扎实：",{"type":39,"tag":276,"props":277,"children":278},"ul",{},[279,285,290,295],{"type":39,"tag":280,"props":281,"children":282},"li",{},[283],{"type":45,"value":284},"**量已经不是算出来的那个量。**絮出来的部分不再处于溶解状态，液体里还剩多少有效成分无从知晓，事先算好的每一个数字随之作废。",{"type":39,"tag":280,"props":286,"children":287},{},[288],{"type":45,"value":289},"**微粒不该进组织。**配伍不当产生的沉淀，在药品安全领域是公认的不溶性微粒污染来源；皮下的后果通常是局部的，从刺激到肉芽肿——异物反应形成的、摸得到的硬结。",{"type":39,"tag":280,"props":291,"children":292},{},[293],{"type":45,"value":294},"**针头可能堵。**固体絮状物和胰岛素针那道极细的通道本就不搭，而且部分堵塞从外面未必看得出来。",{"type":39,"tag":280,"props":296,"children":297},{},[298],{"type":45,"value":299},"**重新溶开不等于没发生过。**加温或者轻晃，也许能让物质在外观上回到溶液里，但外观说明不了分子是否完整、是否已经成了聚集体。而聚集体正是肽可能获得免疫原性的那条路径。",{"type":39,"tag":47,"props":301,"children":302},{},[303],{"type":45,"value":304},"有三条路常有人走，每一条都让事情更糟：把针管里的液体退回西林瓶，等于把析出带进了储备瓶；冲一冲接着用下去，未知的量依然未知；用滤器，颗粒连同有效成分一起被拿走。",{"type":39,"tag":47,"props":306,"children":307},{},[308,313],{"type":39,"tag":63,"props":309,"children":310},{},[311],{"type":45,"value":312},"西林瓶本身",{"type":45,"value":314},"适用同一套判断：发浑、有絮状物或者挂丝的那一瓶已经报废；澄清但瓶底有沉淀、晃动之后化不开的，也一样。",{"type":39,"tag":71,"props":316,"children":318},{"id":317},"让问题不出现的那条惯例",[319],{"type":45,"value":317},{"type":39,"tag":47,"props":321,"children":322},{},[323],{"type":45,"value":324},"**一支注射器只装一种肽。**全部内容就这一句。这条惯例背后的每一点都是机理，而不是偏好：",{"type":39,"tag":276,"props":326,"children":327},{},[328,342,347,352,369],{"type":39,"tag":280,"props":329,"children":330},{},[331,333,340],{"type":45,"value":332},"**稀释液决定走向。**文献把生理盐水记为脂化 GLP-1 类肽析出的诱因，凡是用它复溶的东西，都会把那份离子强度一路带下去。两种稀释液之间的差别见",{"type":39,"tag":334,"props":335,"children":337},"a",{"href":336},"\u002Fbacteriostatic-vs-sterile-water",[338],{"type":45,"value":339},"抑菌注射用水与灭菌注射用水",{"type":45,"value":341},"。",{"type":39,"tag":280,"props":343,"children":344},{},[345],{"type":45,"value":346},"**最弱的一环定上限。**溶解度余量最小的那个分子，决定一份混合液撑不撑得住。",{"type":39,"tag":280,"props":348,"children":349},{},[350],{"type":45,"value":351},"**浑浊是一项计时观察。**配伍试验要在规定的静置时间之后判读，因为雾状可能要过几分钟才显出来；头几秒看着清澈的混合液，等于根本还没有被判读过。",{"type":39,"tag":280,"props":353,"children":354},{},[355,360,362,368],{"type":39,"tag":63,"props":356,"children":357},{},[358],{"type":45,"value":359},"剪切力和泡沫促进聚集",{"type":45,"value":361},"，所以文献描述的复溶手法是轻轻滚动，而不是摇晃。药学文献里怎么描述这件事，见",{"type":39,"tag":334,"props":363,"children":365},{"href":364},"\u002Freconstitute-peptides",[366],{"type":45,"value":367},"肽的复溶",{"type":45,"value":341},{"type":39,"tag":280,"props":370,"children":371},{},[372],{"type":45,"value":373},"**目视检查有标准可依。**对着明亮背景检查溶液中有无可见异物，是 USP \u003C790> 与《欧洲药典》2.9.20 所描述的药典检查，《中国药典》通则 0904“可见异物检查法”对应的是同一件事。判读只有两档：澄清就是澄清，没有“基本澄清”这一说。",{"type":39,"tag":71,"props":375,"children":377},{"id":376},"怎么识别析出",[378],{"type":45,"value":376},{"type":39,"tag":380,"props":381,"children":382},"table",{},[383,402],{"type":39,"tag":384,"props":385,"children":386},"thead",{},[387],{"type":39,"tag":388,"props":389,"children":390},"tr",{},[391,397],{"type":39,"tag":392,"props":393,"children":394},"th",{},[395],{"type":45,"value":396},"可见现象",{"type":39,"tag":392,"props":398,"children":399},{},[400],{"type":45,"value":401},"说明",{"type":39,"tag":403,"props":404,"children":405},"tbody",{},[406,420,433,446,459,472],{"type":39,"tag":388,"props":407,"children":408},{},[409,415],{"type":39,"tag":410,"props":411,"children":412},"td",{},[413],{"type":45,"value":414},"白色丝状物或条纹，晃动针管时跟着动",{"type":39,"tag":410,"props":416,"children":417},{},[418],{"type":45,"value":419},"肽已析出，配液不可用",{"type":39,"tag":388,"props":421,"children":422},{},[423,428],{"type":39,"tag":410,"props":424,"children":425},{},[426],{"type":45,"value":427},"乳白色雾状，散不掉",{"type":39,"tag":410,"props":429,"children":430},{},[431],{"type":45,"value":432},"析出或聚集，配液不可用",{"type":39,"tag":388,"props":434,"children":435},{},[436,441],{"type":39,"tag":410,"props":437,"children":438},{},[439],{"type":45,"value":440},"絮状物聚在推杆一端或者底部",{"type":39,"tag":410,"props":442,"children":443},{},[444],{"type":45,"value":445},"固体脱离溶液，配液不可用",{"type":39,"tag":388,"props":447,"children":448},{},[449,454],{"type":39,"tag":410,"props":450,"children":451},{},[452],{"type":45,"value":453},"细小气泡上浮后消失",{"type":39,"tag":410,"props":455,"children":456},{},[457],{"type":45,"value":458},"空气，无害",{"type":39,"tag":388,"props":460,"children":461},{},[462,467],{"type":39,"tag":410,"props":463,"children":464},{},[465],{"type":45,"value":466},"用力晃动后的少量泡沫",{"type":39,"tag":410,"props":468,"children":469},{},[470],{"type":45,"value":471},"机械性的，会自行消退，但聚集仍有可能",{"type":39,"tag":388,"props":473,"children":474},{},[475,480],{"type":39,"tag":410,"props":476,"children":477},{},[478],{"type":45,"value":479},"冷藏后出现、回到室温即消失的结晶",{"type":39,"tag":410,"props":481,"children":482},{},[483],{"type":45,"value":484},"边界情况，不能排除聚集",{"type":39,"tag":47,"props":486,"children":487},{},[488],{"type":45,"value":489},"区分气泡与析出，最省事的判据是时间：气泡上浮并消失，絮状物留下来并悬着。",{"type":39,"tag":71,"props":491,"children":493},{"id":492},"冷静的那部分算账",[494],{"type":45,"value":495},"冷静的那部分：算账",{"type":39,"tag":47,"props":497,"children":498},{},[499,501,507,509,515],{"type":45,"value":500},"这件事里中立的部分，是注射器上的那个数字。已知一支西林瓶里有多少有效成分、又加进了多少抑菌注射用水，",{"type":39,"tag":334,"props":502,"children":504},{"href":503},"\u002Fcalculator",[505],{"type":45,"value":506},"我们的计算器",{"type":45,"value":508},"会把它换算成刻度上的单位——这是单位换算，不是在建议使用任何东西。某支西林瓶什么时候复溶的、在被描述的保存期限内还能放多久，记录这些则是",{"type":39,"tag":334,"props":510,"children":512},{"href":511},"\u002Fpeptides-list",[513],{"type":45,"value":514},"肽类追踪器",{"type":45,"value":516},"的用处。",{"type":39,"tag":71,"props":518,"children":520},{"id":519},"常见问题",[521],{"type":45,"value":519},{"type":39,"tag":523,"props":524,"children":525},"h3",{"id":18},[526],{"type":45,"value":18},{"type":39,"tag":47,"props":528,"children":529},{},[530],{"type":45,"value":19},{"type":39,"tag":523,"props":532,"children":533},{"id":21},[534],{"type":45,"value":21},{"type":39,"tag":47,"props":536,"children":537},{},[538],{"type":45,"value":22},{"type":39,"tag":523,"props":540,"children":541},{"id":24},[542],{"type":45,"value":24},{"type":39,"tag":47,"props":544,"children":545},{},[546],{"type":45,"value":25},{"type":39,"tag":523,"props":548,"children":549},{"id":27},[550],{"type":45,"value":27},{"type":39,"tag":47,"props":552,"children":553},{},[554],{"type":45,"value":28},{"type":39,"tag":523,"props":556,"children":557},{"id":30},[558],{"type":45,"value":30},{"type":39,"tag":47,"props":560,"children":561},{},[562],{"type":45,"value":31},{"type":39,"tag":523,"props":564,"children":566},{"id":565},"混合后的注射器很清澈是不是就说明配伍没问题",[567],{"type":45,"value":33},{"type":39,"tag":47,"props":569,"children":570},{},[571],{"type":45,"value":34},{"type":39,"tag":71,"props":573,"children":575},{"id":574},"参考来源",[576],{"type":45,"value":574},{"type":39,"tag":276,"props":578,"children":579},{},[580,593,605,610,615],{"type":39,"tag":280,"props":581,"children":582},{},[583,585],{"type":45,"value":584},"美国药典通则 \u003C790> 与 \u003C1790>，可见异物与目视检查（",{"type":39,"tag":334,"props":586,"children":590},{"href":587,"rel":588},"https:\u002F\u002Fwww.usp.org%EF%BC%89%E3%80%82",[589],"nofollow",[591],{"type":45,"value":592},"https:\u002F\u002Fwww.usp.org）。",{"type":39,"tag":280,"props":594,"children":595},{},[596,598],{"type":45,"value":597},"《欧洲药典》2.9.20，微粒污染：可见异物，EDQM（",{"type":39,"tag":334,"props":599,"children":602},{"href":600,"rel":601},"https:\u002F\u002Fwww.edqm.eu%EF%BC%89%E3%80%82",[589],[603],{"type":45,"value":604},"https:\u002F\u002Fwww.edqm.eu）。",{"type":39,"tag":280,"props":606,"children":607},{},[608],{"type":45,"value":609},"《中国药典》通则 0904，可见异物检查法。",{"type":39,"tag":280,"props":611,"children":612},{},[613],{"type":45,"value":614},"Trissel's Handbook on Injectable Drugs（ASHP），注射剂配伍的标准参考书。",{"type":39,"tag":280,"props":616,"children":617},{},[618,620,626],{"type":45,"value":619},"关于肽与蛋白溶液稳定性（pH、离子强度、聚集）的综述，例如 Manning 等，",{"type":39,"tag":621,"props":622,"children":623},"em",{},[624],{"type":45,"value":625},"Pharmaceutical Research",{"type":45,"value":627},"，2010。",{"type":39,"tag":71,"props":629,"children":631},{"id":630},"小结",[632],{"type":45,"value":630},{"type":39,"tag":47,"props":634,"children":635},{},[636],{"type":45,"value":637},"析出不是材料出了问题，而是化学。没有缓冲能力的溶液，pH 一滑向等电点，或者盐浓度一升高，最脆弱的那个分子就失去溶解度，掉了出来。",{"type":39,"tag":47,"props":639,"children":640},{},[641],{"type":45,"value":642},"针管里挂着丝或者雾的注射器就是报废品，不过滤，也不重新溶开。让问题压根不出现的那条惯例平平无奇：一支注射器只装一种肽。",{"title":7,"searchDepth":644,"depth":644,"links":645},2,[646,647,648,649,650,651,652,653,654,655,656,665,666],{"id":73,"depth":644,"text":73},{"id":110,"depth":644,"text":110},{"id":139,"depth":644,"text":139},{"id":185,"depth":644,"text":185},{"id":214,"depth":644,"text":217},{"id":256,"depth":644,"text":259},{"id":267,"depth":644,"text":267},{"id":317,"depth":644,"text":317},{"id":376,"depth":644,"text":376},{"id":492,"depth":644,"text":495},{"id":519,"depth":644,"text":519,"children":657},[658,660,661,662,663,664],{"id":18,"depth":659,"text":18},3,{"id":21,"depth":659,"text":21},{"id":24,"depth":659,"text":24},{"id":27,"depth":659,"text":27},{"id":30,"depth":659,"text":30},{"id":565,"depth":659,"text":33},{"id":574,"depth":644,"text":574},{"id":630,"depth":644,"text":630},"markdown","content:mixing-peptides:zh.md","content","mixing-peptides\u002Fzh.md","mixing-peptides\u002Fzh","md"]